These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 8620676

  • 21. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE, Nicholls AJ, Kamm BR.
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
    Rubin P, Dubé L, Braeckman R, Swanson L, Hansen R, Albert D, Carter G.
    Agents Actions Suppl; 1991 Jun; 35():103-16. PubMed ID: 1781415
    [Abstract] [Full Text] [Related]

  • 23. Stereoselective pharmacokinetics of oxprenolol and its glucuronides in humans.
    Laethem ME, Lefebvre RA, Belpaire FM, Vanhoe HL, Bogaert MG.
    Clin Pharmacol Ther; 1995 Apr; 57(4):419-24. PubMed ID: 7712670
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and metabolism of genaconazole, a potent antifungal drug, in men.
    Lin C, Kim H, Radwanski E, Affrime M, Brannan M, Cayen MN.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):92-6. PubMed ID: 8787886
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL, Suri A.
    Clin Pharmacokinet; 1999 Jan; 37 Suppl 2():41-51. PubMed ID: 10702886
    [Abstract] [Full Text] [Related]

  • 26. Vigabatrin. Clinical pharmacokinetics.
    Rey E, Pons G, Olive G.
    Clin Pharmacokinet; 1992 Oct; 23(4):267-78. PubMed ID: 1395360
    [Abstract] [Full Text] [Related]

  • 27. Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers.
    Wong SL, Drajesk J, Chang MS, Witt G, Awni WM.
    Biopharm Drug Dispos; 1998 Apr; 19(3):159-62. PubMed ID: 9569998
    [Abstract] [Full Text] [Related]

  • 28. The clinical pharmacokinetics of levofloxacin.
    Fish DN, Chow AT.
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [Abstract] [Full Text] [Related]

  • 29. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C, Hemanthkumar AK, Gurumurthy P, Venkatesan P.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [Abstract] [Full Text] [Related]

  • 30. The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine.
    Awni WM, Cavanaugh JH, Leese P, Kasier J, Cao G, Locke CS, Dube LM.
    Eur J Clin Pharmacol; 1997 Nov; 52(1):49-54. PubMed ID: 9143867
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers.
    Da Ros L, Squassante L, Milleri S.
    Clin Pharmacokinet; 2003 Nov; 42(1):99-106. PubMed ID: 12489980
    [Abstract] [Full Text] [Related]

  • 36. Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.
    Fleishaker JC.
    Clin Pharmacokinet; 2000 Dec; 39(6):413-27. PubMed ID: 11192474
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate.
    Geisslinger G, Menzel S, Wissel K, Brune K.
    Br J Clin Pharmacol; 1995 Jul; 40(1):73-5. PubMed ID: 8527271
    [Abstract] [Full Text] [Related]

  • 39. Clinical pharmacokinetics of flurbiprofen and its enantiomers.
    Davies NM.
    Clin Pharmacokinet; 1995 Feb; 28(2):100-14. PubMed ID: 7736686
    [Abstract] [Full Text] [Related]

  • 40. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G, Monti N, Brogin G, Gallina M, Eandi M, Persiani S, Bani M, Della Pepa C, Zara G, Strolin Benedetti M.
    Chirality; 1997 Feb; 9(3):297-302. PubMed ID: 9176996
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.